Search tips
Search criteria 


Logo of jcmPermissionsJournals.ASM.orgJournalJCM ArticleJournal InfoAuthorsReviewers
J Clin Microbiol. 2009 February; 47(2): 451–452.
Published online 2008 December 3. doi:  10.1128/JCM.01736-08
PMCID: PMC2643666

Evaluation of a Screening Test for Detection of Giardia and Cryptosporidium Parasites [down-pointing small open triangle]


The Giardia/Cryptosporidium Chek test (TechLab, Inc.), a screening test for Giardia and Cryptosporidium, was evaluated with 136 fecal samples. Using the results of the Giardia II test and Cryptosporidium II test as gold standards, it was 98.4% sensitive and 100% specific and had positive and negative predictive values of 98.7% and 99.3%.

Giardia is a binucleated flagellated protozoan parasite which exists as a noninfectious trophozoite inhabiting the small intestine or as a highly infectious cyst form (7). The noninfectious trophozoite can last only a matter of hours outside the body, while the infectious cyst form can survive for several days in an external environment (7). Cryptosporidium is also an enteric protozoan parasite of vertebrates (8). Both parasites are transmitted through fecal-oral routes (9, 10, 26, 32), by consumption of contaminated food or water (9, 18, 30, 32, 33), or by sexual transmission (33). They cause common intestinal waterborne diseases in the United States (6, 20, 21, 31). Contraction of the diseases is more frequent among younger children, and they especially pose a threat to immune system-compromised individuals (1, 3, 19, 31, 33). In developing countries, crowded urban areas and a lack of sanitation enhance the risk of transmission (4, 5, 22, 30, 33). There is a need for rapid diagnostic tests, especially for point-of-care use and in waterborne-outbreak investigations (2, 16, 24, 25, 27-29, 30, 31, 34).

Giardia/Cryptosporidium Chek is an immunoassay developed to allow the simultaneous qualitative detection of Giardia and Cryptosporidium antigens in fecal specimens. It is a microtiter plate enzyme-linked immunosorbent assay (ELISA) that detects both Giardia and Cryptosporidium cyst antigens from fecal specimens. Positive results of the test signify the presence of either Giardia or Cryptosporidium or the presence of both pathogens. It should be noted, however, that the test cannot distinguish between the two pathogens.

One hundred thirty-six fecal samples, of both diarrheal and nondiarrheal specimens, were tested at the International Centre for Diarrheal Disease Research, Bangladesh. As a qualitative standard of measurement of the presence/absence of either or both of the antigens, individual ELISAs for Giardia and Cryptosporidium, the Giardia II test and the Cryptosporidium II test (TechLab), were used as the gold standard. All specimens with discrepant results were retested by the Giardia II test and the Cryptosporidium II test and by PCR tests. If the specimen was positive with the Giardia II test and/or the Cryptosporidium II test and further confirmed by the PCR tests, the specimen was considered a true positive.

The Giardia/Cryptosporidium Chek assay was used in accordance to the manufacturer's directions. Four hundred microliters of diluent was added to 100 μl of fecal sample in a tube and was mixed thoroughly. One hundred microliters of diluent and 50 μl of the mixture were added to the microassay plate and was left at room temperature for incubation for 1 h. The wells were washed five times using the wash solution provided, and a drop (50 μl) of conjugate was added to each well, which was incubated at room temperature for 30 min, followed by washing. Subsequently, 2 drops (100 μl) of substrate was added to each well. After 10 min of incubation at room temperature, 1 drop (50 μl) of stop solution was added to each well. The plate was read using an ELISA reader, with ≥0.150 being the cutoff for the sample to be considered positive at an optical density of 450 nm.

Using the results of the individual ELISAs as gold standards, the Giardia/Cryptosporidium Chek assay had a sensitivity of 98.4%, 100% specificity, a positive predictive value of 98.7%, and a negative predictive value of 99.3% (Table (Table1).1). One specimen, giving a false-negative result by the Giardia/Cryptosporidium Chek test, was found to be positive for Cryptosporidium by the Cryptosporidium II test. The optical density at 450 nm of the false-negative specimen, 0.146, however, was very close to the cutoff value of the Giardia/Cryptosporidium Chek test, 0.15. The use of Giardia II test and Cryptosporidium II test ELISAs, instead of the use of PCR, as a measurement of the standard may have overestimated the sensitivity of Giardia/Cryptosporidium Chek. Nonetheless, the results of the Giardia/Cryptosporidium Chek test show comparable sensitivity to other diagnostic tests.

Performance of Giardia/Cryptosporidium Chek test

Already-existing rapid diagnostic tests for Cryptosporidium and Giardia include the ImmunoCard Stat! test (Meridian Bioscience, Inc.) (11), the ColorPAC Giardia/Cryptosporidium test (Becton Dickinson) (12), and the Triage parasite panel (Biosite Diagnostics, San Diego, CA) (13). The other diagnostic tests take comparable amounts of time to perform and with the exception of ImmunoCard Stat! appear to have comparable sensitivities and specificities to those of the Giardia/Cryptosporidium Chek test (11, 12, 14, 15, 17, 20, 23). The Giardia/Cryptosporidium Chek test's ability to test multiple specimens simultaneously, 96 on each plate, offers the promise of a cost- and time-efficient means of screening stool samples for these infections.


S.Y. is a Center for Global Health Scholar. This work was supported by NIH grant AI-43596 to W.A.P.

We thank TechLab for providing the Giardia/Cryptosporidium Chek and Giardia II and Cryptosporidium II stool antigen tests.


[down-pointing small open triangle]Published ahead of print on 3 December 2008.


1. Blanshard, C., A. M. Jackson, D. C. Shanson, N. Francis, and B. G. Gazzard. 1992. Cryptosporidiosis in HIV-seropositive patients. Q. J. Med. 85813-823. [PubMed]
2. Caccio, S. M., et al. 2005. Unravelling Cryptosporidium and Giardia epidemiology. Trends Parasitol. 21430-437. [PubMed]
3. Colford, J. M., Jr., I. B. Tager, A. M. Hirozawa, G. F. Lemp, T. Aragon, and C. Petersen. 1996. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival. Am. J. Epidemiol. 144807-816. [PubMed]
4. Corso, P. S., M. H. Kramer, K. A. Blair, D. G. Addiss, J. P. Davis, and A. C. Haddix. 2003. Cost of illness in the 1993 waterborne Cryptosporidium outbreak, Milwaukee, Wisconsin. Emerg. Infect. Dis. 9426-431. [PMC free article] [PubMed]
5. Crompton, D. W. T., and L. Savioli. 1993. Intestinal parasitic infections and urbanization. Bull. W. H. O. 711-7. [PubMed]
6. Dietz, V., and J. M. Roberts. 2000. National surveillance for infection with Cryptosporidium parvum 1995-1998: what have we learned? Public Health Rep. 115358-363. [PMC free article] [PubMed]
7. Erlandsen, L. S., and E. A. Meyer (ed.). 1984. Giardia and giardiasis: biology, pathogenesis and epidemiology. Plenum Press, New York, NY.
8. Fayer, R., and L. P. Ungar. 1986. Cryptosporidium spp and cryptosporidiosis. Microbiol. Rev. 50458-483. [PMC free article] [PubMed]
9. Fayer, R., U. Morgan, and S. J. Upton. 2000. Epidemiology of Cryptosporidium: transmission, detection and identification. Int. J. Parasitol. 301305-1322. [PubMed]
10. Fayer, R., P. A. Fair, G. D. Bossart., and M. Santin. 2008. Examination of naturally exposed bottlenose dolphins (Tursiops truncatus) for Microsporidia, Cryptosporidium, and Giardia. J. Parasitol. 94143-147. [PubMed]
11. Garcia, L. S., R. Y. Shimizu, S. Novak, M. Carroll, and F. Chan. 2003. Commercial assay for detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens by rapid solid-phase qualitative immunochromatography. J. Clin. Microbiol. 41209-212. [PMC free article] [PubMed]
12. Garcia, L. S., and R. Y. Shimizu. 2000. Detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens using the ColorPAC combination rapid solid-phase qualitative immunochromatographic assay. J. Clin. Microbiol. 381267-1268. [PMC free article] [PubMed]
13. Garcia, L. S., R. Y. Shimizu, and C. N. Bernard. 2000. Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the Triage parasite panel enzyme immunoassay. J. Clin. Microbiol. 383337-3340. [PMC free article] [PubMed]
14. Garcia, L. S., and R. Y. Shimizu. 1997. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J. Clin. Microbiol. 351526-1529. [PMC free article] [PubMed]
15. Garcia, L. S., A. C. Shum, and D. A. Bruckner. 1992. Evaluation of a new monoclonal antibody combination reagent for direct fluorescent detection of Giardia cysts and Cryptosporidium oocysts in human fecal specimens. J. Clin. Microbiol. 303255-3257. [PMC free article] [PubMed]
16. Haque, R., et al. 2007. Multiplex real-time PCR assay for detection of Entamoeba histolytica, Giardia intestinalis, and Cryptosporidium spp. Am. J. Trop. Med. Hyg. 76713-717. [PubMed]
17. Hayes, E. B., T. D. Matte, T. R. O'Brien, et al. 1989. Large community outbreak of cryptosporidiosis due to contamination of a filtered public water supply. N. Engl. J. Med. 3201372-1376. [PubMed]
18. Hellard, M., J. Hocking, J. Willis, G. Dore, and C. Fairley. 2003. Risk factors leading to Cryptosporidium infection in men who have sex with men. Sex. Transm. Infect. 79412-414. [PMC free article] [PubMed]
19. Hunter, P. R., and G. Nichols. 2002. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin. Microbiol. Rev. 15145-154. [PMC free article] [PubMed]
20. Johnston, S. P., M. M. Ballard, M. J. Beach, L. Causer, and P. P. Wilkins. 2003. Evaluation of three commercial assays for detection of Giardia and Cryptosporidium organisms in fecal specimens. J. Clin. Microbiol. 41623-626. [PMC free article] [PubMed]
21. Kappus, K. D., R. G. Lundgren, D. D. Juranek, et al. 1994. Intestinal parasitism in the United States. Update on a continuing problem. Am. J. Trop. Med. Hyg. 50705-713. [PubMed]
22. Karanis, P., et al. 2007. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J. Water Health 51-38. [PubMed]
23. Katanik, M. T., S. K. Schneider, J. E. Rosenblatt, G. S. Hall, and G. W. Procop. 2001. Evaluation of ColorPAC Giardia/Cryptosporidium rapid assay and ProSpecT Giardia/Cryptosporidium microplate assay for detection of Giardia and Cryptosporidium in fecal specimens. J. Clin. Microbiol. 394523-4525. [PMC free article] [PubMed]
24. Leo, M., R. Haque, M. Kabir, S. Roy, R. M. Lahlou, D. Mondal, et al. 2006. Evaluation of Entamoeba histolytica antigen and antibody point-of-care tests for the rapid diagnosis of amebiasis. J. Clin. Microbiol. 444569-4571. [PMC free article] [PubMed]
25. Mac Kenzie, W. R., N. J. Hoxie, and M. E. Proctor. 1994. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N. Engl. J. Med. 331161-167. [PubMed]
26. Meinhardt, P. L., D. P. Casemore, and K. B. Miller. 1996. Epidemiologic aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiol. Rev. 18118-136. [PubMed]
27. Nash, T. E., D. A. Herrington, and M. M. Levine. 1987. Usefulness of an enzyme-linked immunosorbent assay for detection of Giardia antigen in feces. J. Clin. Microbiol. 251169-1171. [PMC free article] [PubMed]
28. Ng, C. T., C. A. Gilchrist, A. Lane, S. Roy, R. Haque, and E. R. Houpt. 2005. Multiplex real-time PCR assay using Scorpion probes and DNA capture for genotype-specific detection of Giardia lamblia on fecal samples. J. Clin. Microbiol. 431256-1260. [PMC free article] [PubMed]
29. Phillips, S. C., D. Mildvan, and D. C. Williams. 1981. Sexual transmission of enteric protozoa and helminths in a venereal disease clinic population. N. Engl. J. Med. 305603-606. [PubMed]
30. Savioli, L., H. Smith, and A. Thompson. 2006. Giardia and Cryptosporidium join the ‘Neglected Diseases Initiative.’ Trends Parasitol. 22203-208. [PubMed]
31. Skeels, M. R., R. Sokolow, C. V. Hubbard, J. K. Andrus, and J. Baisch. 1990. Cryptosporidium infection in Oregon public health clinic patients 1985-88: the value of statewide laboratory surveillance. Am. J. Public Health 80305-308. [PubMed]
32. Smith, H. V., S. M. Caccio, A. Tait, J. McLauchlin, and A. R. C. Thompson. 2006. Tools for investigating the environmental transmission of Cryptosporidium and Giardia. Trends Parasitol. 22160-167. [PubMed]
33. Xiao, L., R. Fayer, U. Ryan, and S. J. Upton. 2004. Cryptosporidium taxonomy: recent advances and implications for public health. Clin. Microbiol. Rev. 1772-97. [PMC free article] [PubMed]
34. Zu, S. X., and R. L. Guerrant. 1993. Cryptosporidiosis. J. Trop. Pediatr. 39132-136. [PubMed]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)